Skip Nav Destination
Issues
Journal Name Change
Former title: Haemostasis.
Pathophysiology of Haemostasis and Thrombosis 2002, Vol. 32, No. 5-6
Special Section
Title Page / Table of Contents / Preface
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 197–206.
https://doi.org/10.1159/000073566
Plenary lectures
Venous thrombosis: the history of knowledge
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 209–212.
https://doi.org/10.1159/000073567
Haemostatic gene polymorphisms in venous and arterial thrombosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 213–215.
https://doi.org/10.1159/000073568
Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 216–217.
https://doi.org/10.1159/000073569
Biochemistry and clinical pharmacology of new anticoagulant agents
Meyer Michel Samama; Grigoris T. Gerotziafas; Ismail Elalamy; Marie Hélène Horellou; Jacqueline Conard
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 218–224.
https://doi.org/10.1159/000073570
Pathogenesis of the acute coronary syndromes and therapeutic implications
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 225–231.
https://doi.org/10.1159/000073571
State of the art lectures
Advances in the genotyping of thrombosis genetic risk factors: clinical and laboratory implications
José Manuel Cabeda; Mónica Pereira; José Miguel Oliveira; Alexandra Estevinho; Irene Pereira; Sara Morais; Benvindo Justiça; Manuel Campos
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 235–240.
https://doi.org/10.1159/000073572
Inherited Abnormalities in the protein C Activation Pathway
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 241–244.
https://doi.org/10.1159/000073573
Laboratory diagnosis of thrombophilic states: where do we stand?
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 245–248.
https://doi.org/10.1159/000073574
The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 249–253.
https://doi.org/10.1159/000073575
Problems related to counseling in genetic thrombophilias
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 254–257.
https://doi.org/10.1159/000073576
Clinical aspects of venous thrombophilia
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 258–262.
https://doi.org/10.1159/000073577
The red blood cell in vascular occlusion
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 263–268.
https://doi.org/10.1159/000073578
The insulin resistance syndrome: implications for thrombosis and cardiovascular disease
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 269–273.
https://doi.org/10.1159/000073579
Endothelial dysfunction and cardiovascular disease
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 274–277.
https://doi.org/10.1159/000073580
Value and limitation of meta-analysis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 278–281.
https://doi.org/10.1159/000073581
Clinical use of novel antithrombotic agents in the management of acute coronary syndromes
Giovanni Melandri; Pierluigi Tricoci; Chiara Melloni; Samuele Nanni; Franco Semprini; Francesco Fallani; Angelo Branzi
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 282–288.
https://doi.org/10.1159/000073582
Heparin-induced thrombocytopenia: Pathophysiology and new treatment options
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 289–294.
https://doi.org/10.1159/000073583
Juvenile arteritis revisited: Buerger’s disease – Takayasu’s disease
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 295–298.
https://doi.org/10.1159/000073584
Regional thrombolysis in lower limb ischemia: new pharmacological and nonpharmacological aspects
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 299–302.
https://doi.org/10.1159/000073585
Dermatan Sulphate as an Antithrombotic Drug
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 303–307.
https://doi.org/10.1159/000073586
Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 308–311.
https://doi.org/10.1159/000073587
‘FOCUS ON’ session: Thrombosis and cardiovascular disease in women: ...
Thrombophilia in young women candidate to the pill: reasons for and against screening
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 315–317.
https://doi.org/10.1159/000073588
Thrombophilias as risk factors for disorders of pregnancy and fetal damage
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 318–321.
https://doi.org/10.1159/000073589
Thrombosis during pregnancy: risk factors, diagnosis and treatment
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 322–324.
https://doi.org/10.1159/000073590
Menopause and cardiovascular risk
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 325–328.
https://doi.org/10.1159/000073591
Hormone replacement therapy: prothrombotic vs. protective effects
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 329–332.
https://doi.org/10.1159/000073592
FOCUS ON session: Thombophilia and thrombosis between genes and environment
Modulation of Thrombophilia Genes by Environmental Factors
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 335–337.
https://doi.org/10.1159/000076692
‘FOCUS ON’ session: Thombophilia and thrombosis between genes and environment
Search for new thrombosis-related genes through intermediate phenotypes. Genetic and household effects
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 338–340.
https://doi.org/10.1159/000073593
Air travel and thrombosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 341–342.
https://doi.org/10.1159/000073594
Unusual forms of venous thrombosis and thrombophilia
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 343–345.
https://doi.org/10.1159/000073595
Infection and venous thrombosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 346–348.
https://doi.org/10.1159/000073596
Air pollution and thrombosis: an experimental approach
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 349–350.
https://doi.org/10.1159/000073597
‘FOCUS ON’ session: Nutrition and antioxidants in vascular disease and thrombosis
A meta-analysis of studies on wine and beer and cardiovascular disease
Giovanni de Gaetano; Augusto Di Castelnuovo; Serenella Rotondo; Licia Iacoviello; Maria Benedetta Donati
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 353–355.
https://doi.org/10.1159/000073598
Red and white wine differently affect collagen-induced platelet aggregation
Pasquale Pignatelli; Luisa Lenti; Fabio M. Pulcinelli; Roberto Catasca; Gloria Saccani; Giuseppe Germanò; Antonella Marcoccia; Maria Assunta Silvestri; Andrea Ghiselli; Francesco Violi
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 356–358.
https://doi.org/10.1159/000073599
Oxidative stress in endothelial cell dysfunction and thrombosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 359–360.
https://doi.org/10.1159/000073600
Polyunsaturated fatty acids, thrombosis and vascular disease
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 361–364.
https://doi.org/10.1159/000073601
‘FOCUS ON’ session: Carotid stenosis. Epidemiology, natural history and ...
Cardiovascular risk assessment using ultrasound: the value of arterial wall changes including the presence, severity and character of plaques
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 367–370.
https://doi.org/10.1159/000073602
Ultrasound plaque characterisation, genetic markers and risks
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 371–377.
https://doi.org/10.1159/000073603
The natural history of patients with carotid stenosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 378–380.
https://doi.org/10.1159/000073604
Management of patients with carotid stenosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 381–385.
https://doi.org/10.1159/000073605
‘FOCUS ON’ session: Angiogenesis and gene therapy in cardiovascular disease
Gene therapy for bypass graft failure and restenosis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 389–391.
https://doi.org/10.1159/000073606
SATELLITE SYMPOSIUM – Emerging concepts in the management of venous ...
Areas of uncertainty and unresolved issues in the management of venous thromboembolism
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 395–397.
https://doi.org/10.1159/000073607
Emerging concepts in thromboprophylaxis
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 398–400.
https://doi.org/10.1159/000073608
Pharmacology of second generation low molecular weight heparins
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 401–402.
https://doi.org/10.1159/000073609
Prophylaxis of venous thromboembolism in orthopaedic surgery
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 403–405.
https://doi.org/10.1159/000073610
Treatment of venous thromboembolism: experience with bemiparin
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 406–407.
https://doi.org/10.1159/000073611
Further Section
Author Index
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 409–410.
https://doi.org/10.1159/000073612
Author Index Vol. 32, 2002
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 411.
https://doi.org/10.1159/000073613
Subject Index Vol. 32, 2002
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 412.
https://doi.org/10.1159/000073614
Contents Vol. 32, 2002
Pathophysiology of Haemostasis and Thrombosis (2002) 32 (5-6): 415–416.
https://doi.org/10.1159/000073615
